Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients

INTRODUCTION: Calcimimetics improve parameters of secondary hyperparathyroidism (sHPT) but are mostly initiated when patients have severe disease, potentially limiting effectiveness. We evaluated the effects of etelcalcetide on lowering intact parathyroid hormone, calcium, and phosphate at different...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int Rep
Autors principals: Cunningham, John, Block, Geoffrey A., Chertow, Glenn M., Cooper, Kerry, Evenepoel, Pieter, Iles, Jan, Sun, Yan, Ureña-Torres, Pablo, Bushinsky, David A.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6611952/
https://ncbi.nlm.nih.gov/pubmed/31317120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2019.04.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars